Search
for
Sort by
Research 871–900 of 1000+
- The Hair Follicle
- Effect of sinapic acid on hair growth promoting in human hair follicle dermal papilla cells via Akt activation
- Hyaluronic acid (HA)-based hydrogels for full-thickness wound repairing and skin regeneration
- Clinical markers of androgenicity in acne vulgaris
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Hirsutism: A Clinico-investigative Study
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Assessment, diagnosis and treatment of a patient with hirsutism
- An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- Carbamazepine-Induced Hair Loss
- Improving Posttraumatic Facial Scars
- Oligomenorrhoea in Exercising Women
- Decorin promotes proliferation and migration of ORS keratinocytes and maintains hair anagen in mice
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Accelerated Wound Healing Using Nanoparticles
- Dermatosis associated with menopause
- The local hypothalamic–pituitary–adrenal axis in cultured human dermal papilla cells
- On the geographies of hair: Exploring the entangled margins of the bordered body
- Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness
- Vitamin D Receptor Gene Polymorphism In Chronic Telogen Effluvium; A Case-Control Study
- Skin eruptions specific to pregnancy: an overview
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- Problems in pattern alopecia
- Techniques for the discovery and evaluation of drugs against alopecia
- Telogen effluvium in the new SARS‐CoV‐2 era
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- ADRENAL ONCOCYTOMA IN CHILDREN – case report
- Ottawa, Ontario, Canada, February 13–16, 2013
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty